Medical Debt In The US: Associations With Cancer Screening, Mortality, And Health Status Odysseas P. Chatzipanagiotou, Andrea Baldo, Miho Akabane, Azza Sarfraz, Areesh Mevawalla, Jasmine King, Razeen Thammachack, and Timothy M. Pawlik

https://www.healthaffairs.org/doi/10.1377/hlthaff.2025.00869

Potential Impact of Tariffs on Active Pharmaceutical Ingredients on the Price of U.S.-Made Generic Drugs

https://academic.oup.com/healthaffairsscholar/advance-article/doi/10.1093/haschl/qxaf247/8402426?rss=1&login=false

December 2025 | Cancer Drugs, Medical Debt, Cybersecurity & More

https://www.healthaffairs.org/toc/hlthaff/44/12

ANNOUNCEMENT – AGE-FRIENDLY HEALTH

https://www.healthaffairs.org/request-for-abstracts/age-friendly-health-2025?utm_campaign=rfa&utm_medium=email&_hsenc=p2ANqtz-94FpjKdMyEtZgrHZqVCF72YVGIwcFtbjzQ_nUuyq1SaO6jaVOikgpBr2NTKDcn3T6yrl_aWQdYhTZg4bU3WTSdM5WqEw&_hsmi=395887403&utm_content=afh&utm_source=hasu

Proposed Federal Rules Target Heatlh Care For Transgender Youth (Part 2) Katie Keith

https://www.healthaffairs.org/content/forefront/proposed-federal-rules-target-heatlh-care-transgender-youth-part-2

Proposed Federal Rules Target Health Care For Transgender Youth (Part 1) Katie Keith

https://www.healthaffairs.org/content/forefront/proposed-federal-rules-target-health-care-transgender-youth-part-1

Benchmarking Drug Prices To Inflation Overlooks What Truly Matters: Value William V. Padula

https://www.healthaffairs.org/content/forefront/why-benchmarking-drug-prices-inflation-overlooks-truly-matters-value